Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota.
The Retina Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania.
Ophthalmology. 2024 Aug;131(8):943-949. doi: 10.1016/j.ophtha.2024.01.028. Epub 2024 Jan 26.
Opioid prescriptions continue to carry significant short- and long-term systemic risks, even after ophthalmic surgery. The goal of this study was to identify any association of opioid prescription, after ophthalmic surgery, with postoperative hospitalization, opioid overdose, opioid dependence, and all-cause mortality.
Retrospective, cross-sectional analysis.
Patients undergoing an ophthalmic surgery in the OptumLabs Data Warehouse.
We used deidentified administrative claims data from the OptumLabs Data Warehouse to create 3 cohorts of patients for analysis from January 1, 2016, to June 30, 2022. The first cohort consisted of 1-to-1 propensity score-matched patients who had undergone ophthalmic surgery and had filled a prescription for an opioid and not filled a prescription for an opioid. The second cohort consisted of patients who were considered opioid naïve and had filled a prescription for an opioid matched to patients who had not filled a prescription for an opioid. The last cohort consisted of opioid-naïve patients matched across the following morphine milligram equivalents (MME) groups: ≤ 40, 41-80, and > 80.
Short- and long-term risks of hospitalization, opioid overdose, opioid dependency/abuse, and death were compared between the cohorts.
We identified 1 577 692 patients who had undergone an ophthalmic surgery, with 312 580 (20%) filling an opioid prescription. Among all patients, filling an opioid prescription after an ophthalmic surgery was associated with increased mortality (hazard rate [HR], 1.28; 95% confidence interval [CI], 1.25-1.31; P < 0.001), hospitalization (HR, 1.51; 95% CI, 1.49-1.53; P < 0.001), opioid overdose (HR, 7.31; 95% CI, 6.20-8.61, P < 0.001), and opioid dependency (HR, 13.05; 95% CI, 11.48-14.84; P < 0.001) compared with no opioid prescription. Furthermore, we found that higher MME doses of opioids were associated with higher rates of mortality, hospitalization, and abuse/dependence.
Patients who filled an opioid prescription after an ophthalmic surgery experienced higher rates of mortality, hospitalization, episodes of opioid overdose, and opioid dependence compared with patients who did not fill an opioid prescription.
FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references.
即使在眼科手术后,阿片类药物处方仍存在显著的短期和长期全身风险。本研究的目的是确定眼科手术后开阿片类药物处方与术后住院、阿片类药物过量、阿片类药物依赖和全因死亡率之间的任何关联。
回顾性、横断面分析。
在 OptumLabs 数据仓库中接受眼科手术的患者。
我们使用 OptumLabs 数据仓库中的匿名行政索赔数据创建了 3 个队列进行分析,时间范围为 2016 年 1 月 1 日至 2022 年 6 月 30 日。第一个队列由 1 对 1 倾向评分匹配的患者组成,他们接受了眼科手术,并且开了阿片类药物处方,而没有开阿片类药物处方。第二个队列由被认为是阿片类药物-naïve 的患者组成,他们开了阿片类药物处方,与未开阿片类药物处方的患者相匹配。最后一个队列由跨以下吗啡毫克当量 (MME) 组匹配的阿片类药物-naïve 患者组成:≤40、41-80 和 >80。
比较队列之间的短期和长期住院、阿片类药物过量、阿片类药物依赖/滥用和死亡风险。
我们确定了 1577692 名接受了眼科手术的患者,其中 312580 名(20%)开了阿片类药物处方。在所有患者中,眼科手术后开阿片类药物处方与死亡率增加相关(风险比 [HR],1.28;95%置信区间 [CI],1.25-1.31;P<0.001)、住院(HR,1.51;95% CI,1.49-1.53;P<0.001)、阿片类药物过量(HR,7.31;95% CI,6.20-8.61,P<0.001)和阿片类药物依赖(HR,13.05;95% CI,11.48-14.84;P<0.001)与未开阿片类药物处方相比。此外,我们发现较高的 MME 剂量阿片类药物与更高的死亡率、住院率和滥用/依赖率相关。
与未开阿片类药物处方的患者相比,眼科手术后开阿片类药物处方的患者经历更高的死亡率、住院率、阿片类药物过量发作和阿片类药物依赖。
参考文献后可能会发现专有或商业披露。